Detection of in utero marijuana exposure by GC-MS, ultra-sensitive ELISA and LC-TOF-MS using umbilical cord tissue

Journal of Analytical Toxicology

Volumn 37, Issue 7, 2013, Pages 391-394

  Chittamma, A ^a   Marin, S J ^b   Williams, J A ^a   Clark, C ^a   McMillin, G A ^a,c  

^a ARUP LABORATORIES   (United States)

^b ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; DELTA9(11) TETRAHYDROCANNABINOL;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; PRENATAL DRUG EXPOSURE; SENSITIVITY AND SPECIFICITY; TIME OF FLIGHT MASS SPECTROMETRY; TISSUE LEVEL; UMBILICAL CORD;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HALLUCINOGENS; HUMANS; INDICATORS AND REAGENTS; INFANT, NEWBORN; MARIJUANA SMOKING; MASS SPECTROMETRY; PREGNANCY; REPRODUCIBILITY OF RESULTS; SUBSTANCE ABUSE DETECTION; TETRAHYDROCANNABINOL; UMBILICAL CORD;

EID: 84881606213     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bkt052     Document Type: Article

References (16)

1. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. United States of America, Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, 2010. http://www.samhsa.gov/data/NSDUH/2k10NSDUH/2k10Results.pdf (24 February 2013, date last accessed).
2. Substance Abuse and Mental Health Services Administration: Substance Use among Women During Pregnancy and Following Childbirth, the NSDUH Report. The Office of Applied Studies, Substance Abuse and Mental Health Services Administration, 2009. http://www.samhsa.gov/data/2k9/135/PregWoSubUseHTML.pdf (24 February 2013, date last accessed).
3. Jutras-Aswad, D., Dinieri, J.A., Harkany, T., Hurd, Y.L. (2009) Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome. European Archives of Psychiatry and Clinical Neuroscience, 259, 395-412.
4. Hayatbakhsh, M.R., Flenady, V.J., Gibbons, K.S., Kingsbury, A.M., Hurrion, E., Mamun, A.A. et al. (2012) Birth outcomes associated with cannabis use before and during pregnancy. Pediatric Research, 71, 215-219.
5. Cotton, S.W. (2012) Drug testing in the neonate. Clinics in Laboratory Medicine, 32, 449-466.
6. Tsai, J.S. (2007) Immunoassays for the detection of cannabis abuse. In El Sohly, MA (ed). Marijuana and the Cannabinoids, 1st edition, Chapter 7. New York, NY: Humana Press, 145-178.
7. Foltz, R.L. (2007) Mass spectrometric methods for determination of cannabinoids in physiological specimens. In El Sohly, MA (ed). Marijuana and the cannabinoids, 1st edition, Chapter 8. New York, NY: Humana Press, 179-204.
8. Barakauskas, V.E., Davis, R., Krasowski, M.D., McMillin, G.A. (2012) Unresolved discrepancies between cannabinoid test results for infant urine. Clinical Chemistry, 58, 1364-1367.
9. Lozano, J., García-Algar, O., Vall, O., de la Torre, R., Scaravelli, G., Pichini, S. (2007) Biological matrices for the evaluation of in utero exposure to drugs of abuse. Therapeutic Drug Monitoring, 29, 711-734.
10. Montgomery, D., Plate, C., Alder, S.C., Jones, M., Jones, J., Christensen, R.D. (2006) Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium. Journal of Perinatology, 26, 11-14.
11. Montgomery, D.P., Plate, C.A., Jones, M., Jones, J., Rios, R., Lambert, D.K. et al. (2008) Using umbilical cord tissue to detect fetal exposure to illicit drugs: a multicentered study in Utah and New Jersey. Journal of Perinatology, 28, 750-753.
12. de Castro, A., Jones, H.E., Johnson, R.E., Gray, T.R., Shakleya, D.M., Huestis, M.A. (2012) Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes. Therapeutic Drug Monitoring,33, 443-452
13. Buchi, K.F., Suarez, C., Varner, M.W. (2013) The prevalence of prenatal opioid and other drug use in utah. American Journal of Perinatology, 30, 241-244.
14. Marin, S.J., Hughes, J.M., Lawlor, B.G., Clark, C.J., McMillin, G.A. (2012) Rapid screening for 67 drugs and metabolites in serum or plasma by accurate-mass LC-TOF-MS. Journal of Analytical Toxicology, 36, 477-486.
15. El Sohly, M.A., Feng, S. (1998) Delta 9-THC metabolites in meconium: identification of 11-OH-delta 9-THC, 8 beta,11-diOH-delta 9-THC, and 11-nor-delta 9-THC-9-COOH as major metabolites of delta 9-THC. Journal of Analytical Toxicology, 22, 329-335.
16. Coles, R., Clements, T.T., Nelson, G.J., McMillin, G.A., Urry, F.M. (2005) Simultaneous analysis of the Delta9-THC metabolites 11-nor-9-carboxy-delta9-THC and 11-hydroxy-delta9-THC in meconium by GC-MS. Journal of Analytical Toxicology, 29, 522-527.